FDA label 0a1c9bec-694b-412c-bfcf-2ff4df19f53c
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- e58e52c4-50f9-4727-9950-bfefadabb2d0
- SPL ID
- 0a1c9bec-694b-412c-bfcf-2ff4df19f53c
- Version
- 3
- Effective date
- 2012-05-02
- Source export date
- 2026-09-28
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:12:50
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 0a1c9bec-694b-412c-bfcf-2ff4df19f53c | id | |
| spl set id | e58e52c4-50f9-4727-9950-bfefadabb2d0 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS If pain or fever persists, if new symptoms occur, or if redness or swelling is pre- sent, consult your physician immediately because these could be signs of a serious condition. Do not give this product to children under 12 years of age unless directed by a physician. Caution should be exercised when used in patients with pro-static hypertrophy, urinary retention, bladder neck obstruction, increased ocular pressure, and asthma. PRECAUTIONS Information for Patients: Patient consultation should include the following information regarding the proper use of NOREL® SR: • Do not exceed recommended dosage. • May be taken with food, water, or milk to lessen gastric irritation. • Do not drive or operate heavy machinery if drowsi- ness or dizziness occurs. • Concomitant use of alcohol and other central nervous system depressants (hypnotics, sedatives, tranquilizers and anti- anxiety drugs) while tak ing NOREL® SR may have an additive effect on drowsiness. • If a dose is missed, the medication should be taken as soon as possible unless it is almost time for the next dose. Doses should not be doubled. • Swallow extended-release tablets whole; do not crush or chew tablets prior to swallowing.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following adverse effects have been selected on the basis of their potential clinical significance (not necessarily inclusive): allergic reactions, anemia, blood dyscrasias (sore throat and fever, unusual bleeding or bruising, unusual tiredness or weakness), psychotic episodes (mood or mental changes) – usually associated with previous history of psychiatric illness, tightness in chest.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.